These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15969581)

  • 1. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.
    Qiu SR; Wierzbicki A; Salter EA; Zepeda S; Orme CA; Hoyer JR; Nancollas GH; Cody AM; De Yoreo JJ
    J Am Chem Soc; 2005 Jun; 127(25):9036-44. PubMed ID: 15969581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate modulates calcium oxalate crystal growth by face-specific interactions.
    Grohe B; O'Young J; Langdon A; Karttunen M; Goldberg HA; Hunter GK
    Cells Tissues Organs; 2011; 194(2-4):176-81. PubMed ID: 21555861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of hyaluronic acid interaction with calcium oxalate crystals: implication of crystals faces, pH and citrate.
    Lamontagne CA; Plante GE; Grandbois M
    J Mol Recognit; 2011; 24(4):733-40. PubMed ID: 21584883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of crystal surface adhesion in kidney stone disease.
    Wesson JA; Ward MD
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of mixed calcium oxalate dihydrate and monohydrate stones.
    Iwata H; Iio S; Nishio S; Takeuchi M
    Scanning Microsc; 1992 Mar; 6(1):231-7; discussion 237-8. PubMed ID: 1626242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.
    Wang L; Qiu SR; Zachowicz W; Guan X; Deyoreo JJ; Nancollas GH; Hoyer JR
    Langmuir; 2006 Aug; 22(17):7279-85. PubMed ID: 16893227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Pathways for the Molecular Step Growth of Calcium Oxalate Monohydrate Crystal Revealed by In Situ Liquid-Phase Atomic Force Microscopy.
    Cho KR; Lee JH; Seo HS; Ji Y; Park JH; Lee SE; Kim HW; Wu KJJ; Kulshreshtha P
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):37873-37882. PubMed ID: 34327985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy.
    Jung T; Sheng X; Choi CK; Kim WS; Wesson JA; Ward MD
    Langmuir; 2004 Sep; 20(20):8587-96. PubMed ID: 15379479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.
    Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK
    Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.
    Qiu SR; Wierzbicki A; Orme CA; Cody AM; Hoyer JR; Nancollas GH; Zepeda S; De Yoreo JJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1811-5. PubMed ID: 14766970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential switch of biomineral crystal morphology using trivalent ions.
    Touryan LA; Lochhead MJ; Marquardt BJ; Vogel V
    Nat Mater; 2004 Apr; 3(4):239-43. PubMed ID: 15034562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.
    Grohe B; O'Young J; Ionescu DA; Lajoie G; Rogers KA; Karttunen M; Goldberg HA; Hunter GK
    J Am Chem Soc; 2007 Dec; 129(48):14946-51. PubMed ID: 17994739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SEM, XRD and FTIR investigation on crystal growth of calcium oxalate modulated by sodium tartrate].
    Zheng H; Chen CY; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 May; 26(5):874-8. PubMed ID: 16883858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.